These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 26116118)
1. (11)C-acetate PET/CT in pre-therapeutic lymph node staging in high-risk prostate cancer patients and its influence on disease management - a retrospective study. Strandberg S; Karlsson CT; Sundström T; Ögren M; Ögren M; Axelsson J; Riklund K EJNMMI Res; 2014 Dec; 4(1):55. PubMed ID: 26116118 [TBL] [Abstract][Full Text] [Related]
2. [11C]Acetate positron emission tomography-computed tomography imaging of prostate cancer lymph-node metastases correlated with histopathological findings after extended lymphadenectomy. Schumacher MC; Radecka E; Hellström M; Jacobsson H; Sundin A Scand J Urol; 2015 Feb; 49(1):35-42. PubMed ID: 25001948 [TBL] [Abstract][Full Text] [Related]
4. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients. Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686 [TBL] [Abstract][Full Text] [Related]
5. High negative predictive value of 68Ga PSMA PET-CT for local lymph node metastases in high risk primary prostate cancer with histopathological correlation. Rahman LA; Rutagengwa D; Lin P; Lin M; Yap J; Lai K; Mancuso P; Rathore P; Haghighi K; Gassner P; Wong LH; Lalak N Cancer Imaging; 2019 Dec; 19(1):86. PubMed ID: 31829288 [TBL] [Abstract][Full Text] [Related]
7. Lymph node staging with 68Ga-PSMA PET in patients with intermediate and high-risk prostate cancer suitable for radical prostatectomy managed in a prostate cancer unit. Maestroni UV; Campobasso D; Guarino G; Acampora A; Scarlattei M; Ziglioli F; Dinale F; Baldari G; Migliari S; Gasparro D; Ferretti S; Silini EM; Ruffini L Chin Clin Oncol; 2023 Jun; 12(3):22. PubMed ID: 37417288 [TBL] [Abstract][Full Text] [Related]
8. Laparoscopic extended pelvic lymph node (LN) dissection as validation of the performance of [(11) C]-acetate positron emission tomography/computer tomography in the detection of LN metastasis in intermediate- and high-risk prostate cancer. Daouacher G; von Below C; Gestblom C; Ahlström H; Grzegorek R; Wassberg C; Sörensen J; Waldén M BJU Int; 2016 Jul; 118(1):77-83. PubMed ID: 26074275 [TBL] [Abstract][Full Text] [Related]
9. F-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography Has High Diagnostic Value for Pelvic and Distant Staging in Patients with High-risk Penile Carcinoma. Ottenhof SR; Djajadiningrat RS; Versleijen MWJ; Donswijk ML; van der Noort V; Brouwer OR; Graafland NM; Vegt E; Horenblas S Eur Urol Focus; 2022 Jan; 8(1):98-104. PubMed ID: 33685842 [TBL] [Abstract][Full Text] [Related]
15. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
16. Use of gallium-68 prostate-specific membrane antigen positron-emission tomography for detecting lymph node metastases in primary and recurrent prostate cancer and location of recurrence after radical prostatectomy: an overview of the current literature. Luiting HB; van Leeuwen PJ; Busstra MB; Brabander T; van der Poel HG; Donswijk ML; Vis AN; Emmett L; Stricker PD; Roobol MJ BJU Int; 2020 Feb; 125(2):206-214. PubMed ID: 31680398 [TBL] [Abstract][Full Text] [Related]
17. Modelling Study with an Interactive Model Assessing the Cost-effectiveness of Scholte M; Barentsz JO; Sedelaar JPM; Gotthardt M; Grutters JPC; Rovers MM Eur Urol Focus; 2020 Sep; 6(5):967-974. PubMed ID: 30826284 [TBL] [Abstract][Full Text] [Related]
18. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and Franklin A; Yaxley WJ; Raveenthiran S; Coughlin G; Gianduzzo T; Kua B; McEwan L; Wong D; Delahunt B; Egevad L; Samaratunga H; Brown N; Parkinson R; Roberts MJ; Yaxley JW BJU Int; 2021 Jan; 127(1):71-79. PubMed ID: 32524748 [TBL] [Abstract][Full Text] [Related]
19. Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard. Stabile A; Pellegrino A; Mazzone E; Cannoletta D; de Angelis M; Barletta F; Scuderi S; Cucchiara V; Gandaglia G; Raggi D; Necchi A; Karakiewicz P; Montorsi F; Briganti A Eur Urol Oncol; 2022 Feb; 5(1):1-17. PubMed ID: 34538770 [TBL] [Abstract][Full Text] [Related]
20. Distribution of prostate nodes: a PET/CT-derived anatomic atlas of prostate cancer patients before and after surgical treatment. Hegemann NS; Wenter V; Spath S; Kusumo N; Li M; Bartenstein P; Fendler WP; Stief C; Belka C; Ganswindt U Radiat Oncol; 2016 Mar; 11():37. PubMed ID: 26968955 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]